COMMUNIQUÉS West-GlobeNewswire

RECORDATI: BOARD APPROVES THE 2018 ACCOUNTS. SALES € 1,352.2 MILLION (+5.0%), EBITDA € 499.1 MILLION (+9.8%), OPERATING INCOME € 442.2 MILLION (+8.8%) AND NET INCOME € 312.4 MILLION (+8.2%). 2018 DIVIDEND € 0.92 (+8.2%)
28/02/2019
RECORDATI: BOARD APPROVES THE 2018 ACCOUNTS. SALES € 1,352.2 MILLION (+5.0%), EBITDA € 499.1 MILLION (+9.8%), OPERATING INCOME € 442.2 MILLION (+8.8%) AND NET INCOME € 312.4 MILLION (+8.2%). 2018 DIVIDEND € 0.92 (+8.2 [...]
Zealand Pharma announces registration of executive management and an update of the Articles of Association
28/02/2019
Company announcement – No. 02 / 2019 Zealand Pharma announces registration of executive management and an update of the Articles of Association Copenhagen, February 28, 2019 – Zealand Pharma A/S (“Zealand”) (NASDAQ: [...]
Editas Medicine Supports Global Movement to Raise Awareness on Rare Disease Day®
28/02/2019
CAMBRIDGE, Mass., Feb. 28, 2019 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a leading genome editing company, announced today the Company is joining forces with the nearly 30 million Americans living with [...]
SR Scales Announces New Pediatric Scales
28/02/2019
SR635i Design Provides Large Contoured Base with Integrated Scale and Cart TONAWANDA, N.Y., Feb. 28, 2019 (GLOBE NEWSWIRE) -- SR Instruments, a leading manufacturer of purpose-built scales for hospitals, medical clinics [...]
Predictive Technology Group Names Jay M. Moyes to Its Board of Directors
28/02/2019
30-year healthcare veteran brings considerable financial and governance expertise SALT LAKE CITY, Feb. 28, 2019 (GLOBE NEWSWIRE) -- Predictive Technology Group, Inc. (OTC PINK: PRED), a leader in the use of data [...]
Albireo Recognizes Rare Disease Day and Highlights Urgent Need to Support Families Affected by Progressive Familial Intrahepatic Cholestasis (PFIC)
28/02/2019
Advances in research and efforts to build awareness of life-threatening, rare, pediatric liver disease offer new hope for patients and families BOSTON, Feb. 28, 2019 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (NASDAQ: [...]
Sarepta Therapeutics Announces Second Year of Route 79, The Duchenne Scholarship Program
28/02/2019
The Company will award up to 20 academic scholarships to individuals diagnosed with Duchenne muscular dystrophy CAMBRIDGE, Mass., Feb. 28, 2019 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in [...]
Dr. William Chey Highlights Unmet Medical Need of Lactose Intolerance and Potential for Phase 3 Drug Candidate RP-G28 in Expert Call Hosted by Ritter Pharmaceuticals
28/02/2019
LOS ANGELES, Feb. 28, 2019 (GLOBE NEWSWIRE) -- Ritter Pharmaceuticals, Inc. (Nasdaq: RTTR) (“Ritter Pharmaceuticals” or the “Company”), a developer of innovative therapeutic products that modulate the gut microbiome to [...]
Terra Tech Enters into Agreement to Acquire Remainder of Interest in Blüm Reno Dispensary
28/02/2019
IRVINE, Calif., Feb. 28, 2019 (GLOBE NEWSWIRE) -- Terra Tech Corp. ( TRTC ) ("Terra Tech") or (the "Company"), a vertically integrated cannabis-focused agriculture company, today announced it has entered into an [...]
Arbutus to Report Fourth Quarter and Year-End 2018 Financial Results and Provide Corporate Update
28/02/2019
WARMINSTER, Pa., Feb. 28, 2019 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), an industry-leading Hepatitis B Virus (HBV) therapeutic solutions company, today announced that it has scheduled its [...]
BioTelemetry, Inc. Elects Laura Dietch and Tiffany Olson to its Board of Directors
28/02/2019
MALVERN, Pa., Feb. 28, 2019 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT), the leading remote medical technology company focused on the delivery of health information to improve quality of life and reduce cost of [...]
CLS Holdings USA, Inc Redeems All Outstanding Yorkville Convertible Debentures Outstanding
28/02/2019
LAS VEGAS, Feb. 28, 2019 (GLOBE NEWSWIRE) -- CLS Holdings USA Inc. (OTCQB:CLSH) (CSE:CLSH.U) “CLS”, a diversified cannabis company operating as Cannabis Life Sciences, has redeemed all of its convertible debentures [...]
American Cannabis Company, Inc. Announces It Has Secured An Industrial Hemp Services Contract With A New Client In The State Of Alabama & Will Be Working With The University Of Alabama On Hemp Research
28/02/2019
DENVER, CO, Feb. 28, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- American Cannabis Company, Inc. (OTCQB: AMMJ) (“ACC”), a full-service business-to-business cannabis and hemp consulting solutions provider, is pleased to [...]
MyoKardia Reports Fourth Quarter and Full Year 2018 Financial Results
28/02/2019
Company to Host Conference Call and Webcast on March 4, 2019 at 8:30 a.m. ET (5:30 a.m. PT) SOUTH SAN FRANCISCO, Calif., Feb. 28, 2019 (GLOBE NEWSWIRE) -- MyoKardia, Inc. (Nasdaq: MYOK), a clinical-stage [...]
Avinger to Announce Fourth Quarter and Full Year 2018 Financial Results on March 6, 2019
28/02/2019
REDWOOD CITY, Calif., Feb. 28, 2019 (GLOBE NEWSWIRE) -- Avinger, Inc. (Nasdaq: AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for [...]
Hemispherx Biopharma Announces Extension of Rights Offering Period to March 5, 2019
28/02/2019
OCALA, Fla., Feb. 28, 2019 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE American: HEB) (“Hemispherx” or the “Company”), an immuno-pharma R&D and emerging commercial growth company focused on unmet medical [...]
Save the Date: Profound Medical to Host Inaugural Analyst & Investor Day on April 11
28/02/2019
TORONTO, Feb. 28, 2019 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX:PRN; OTCQX:PRFMF) (“Profound” or the “Company”), the only company to provide a therapeutics platform that combines real-time Magnetic Resonance (“MR [...]
Samumed Announces Positive End-of-Phase 2 Meeting with FDA for SM04690 in Knee Osteoarthritis
28/02/2019
STRIDES Phase 3 studies to commence first half of 2019 SAN DIEGO, Feb. 28, 2019 (GLOBE NEWSWIRE) -- Samumed, LLC, announced today that it has successfully completed an End-of-Phase 2 meeting with the U.S. Food and Drug [...]
OncBioMune Announces Consulting Agreement with CATO Research LLC for Developing PGT, a Protein Drug Complex Targeting CD71 for Refractory Cancers
28/02/2019
BATON ROUGE, La., Feb. 28, 2019 (GLOBE NEWSWIRE) -- OncBioMune Pharmaceuticals, Inc. (OTCQB:OBMP) ("OncBioMune" or the "Company"), a clinical-stage biopharmaceutical company engaged in the development of a proprietary [...]

Pages